503 related articles for article (PubMed ID: 27663245)
1. Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
Kim ES; Frampton JE
Drugs; 2016 Oct; 76(15):1485-1492. PubMed ID: 27663245
[TBL] [Abstract][Full Text] [Related]
2. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
McCormack PL
Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
[TBL] [Abstract][Full Text] [Related]
3. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.
Griffiths CE; Stein Gold L; Cambazard F; Kalb RE; Lowson D; Møller A; Paul C
Eur J Dermatol; 2018 Jun; 28(3):356-363. PubMed ID: 29952297
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL
Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
[TBL] [Abstract][Full Text] [Related]
5. Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
Yan R; Jiang S; Wu Y; Gao XH; Chen HD
Indian J Dermatol Venereol Leprol; 2016; 82(2):135-44. PubMed ID: 26924402
[TBL] [Abstract][Full Text] [Related]
6. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707
[TBL] [Abstract][Full Text] [Related]
7. Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam.
Puig L; Carretero G
Actas Dermosifiliogr (Engl Ed); 2019 Mar; 110(2):115-123. PubMed ID: 30031488
[TBL] [Abstract][Full Text] [Related]
8. A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris.
Taraska V; Tuppal R; Olesen M; Bang Pedersen C; Papp K
J Cutan Med Surg; 2016 Jan; 20(1):44-51. PubMed ID: 26224733
[TBL] [Abstract][Full Text] [Related]
9. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
Fenton C; Plosker GL
Am J Clin Dermatol; 2004; 5(6):463-78. PubMed ID: 15663344
[TBL] [Abstract][Full Text] [Related]
10. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
Claréus BW; Houwing R; Sindrup JH; Wigchert S
Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM
Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
[TBL] [Abstract][Full Text] [Related]
13. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
Lambert J; Hol CW; Vink J
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2349-55. PubMed ID: 26337069
[TBL] [Abstract][Full Text] [Related]
14. Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.
Paul C; Leonardi C; Menter A; Reich K; Gold LS; Warren RB; Møller A; Lebwohl M
Am J Clin Dermatol; 2017 Jun; 18(3):405-411. PubMed ID: 28236223
[TBL] [Abstract][Full Text] [Related]
15. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ
Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
Queille-Roussel C; Olesen M; Villumsen J; Lacour JP
Clin Drug Investig; 2015 Apr; 35(4):239-45. PubMed ID: 25708531
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).
Leonardi C; Bagel J; Yamauchi P; Pariser D; Xu Z; Olesen M; Østerdal ML; Stein Gold L
J Drugs Dermatol; 2015 Dec; 14(12):1468-77. PubMed ID: 26659941
[TBL] [Abstract][Full Text] [Related]
18. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.
Eichenfield LF; Ganslandt C; Kurvits M; Schlessinger J
Pediatr Dermatol; 2015; 32(1):28-35. PubMed ID: 25412565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]